Paper35501648
Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice.
Dubinin MV and 3 others. Bull Exp Biol Med, 2022. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice. Papers, record 35501648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35501648
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dystrophin | Major topic |
| Muscular Dystrophy, Duchenne | Major topic |
| Animals | |
| Calcium | |
| Cyclosporine | |
| Ion Transport | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred mdx | |
| Mitochondria, Heart | |
| Mitophagy | |
| Muscle, Skeletal |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34575944 | Alisporivir Improves Mitochondrial Function in Skeletal Muscle of mdx Mice but Suppresses Mitochondrial Dynamics and Biogenesis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34575944 | PubMed |
| 2 | 34572419 | Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient mdx Mice. | Biomedicines | 2021 | https://conductscience.org/library/papers/34572419 | PubMed |
| 3 | 31926263 | Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition. | Biochim Biophys Acta Mol Basis Dis | 2020 | https://conductscience.org/library/papers/31926263 | PubMed |
| 4 | 30143745 | The machineries, regulation and cellular functions of mitochondrial calcium. | Nat Rev Mol Cell Biol | 2018 | https://conductscience.org/library/papers/30143745 | PubMed |
| 5 | 34298968 | Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34298968 | PubMed |
| 6 | 34357020 | The Interplay of Mitophagy and Inflammation in Duchenne Muscular Dystrophy. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34357020 | PubMed |
| 7 | 18641676 | Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18641676 | PubMed |
| 8 | 28899790 | Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28899790 | PubMed |
| 9 | 20637615 | Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice. | Neuromuscul Disord | 2010 | https://conductscience.org/library/papers/20637615 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42757472 | Mitochondria‑associated endoplasmic reticulum membranes in degenerative musculoskeletal disorders: Mechanistic evidence and therapeutic perspectives (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42757472 | PubMed |
| 42744847 | Cyclosporin A triggers a RIG-I-mediated interferon response through multiple cellular processes. | Sci Rep | 2026 | https://conductscience.org/library/papers/42744847 | PubMed |
| 39045055 | Cyclophilin inhibition as a strategy for the treatment of human disease. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39045055 | PubMed |
| 38607013 | Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy. | Cells | 2024 | https://conductscience.org/library/papers/38607013 | PubMed |
| 36768550 | Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768550 | PubMed |
| 36613804 | Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613804 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35501648
GET https://conductscience.org/api/papers/v1/35501648/authors